PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 25, 2002Circulation Journal70 citationsOpen Access

Brugada Syndrome With Ventricular Tachycardia and Fibrillation Related to Hypokalemia.

TATsutomu ArakiTKTetsuo KonnoHIHideki Itoh

Structured PICO

Does hypokalemia contribute to the occurrence of ventricular tachycardia and fibrillation in patients with Brugada syndrome?

P
Population
1 60-year-old man with asymptomatic Brugada syndrome and no history of syncope or family history of sudden death, admitted for bronchial asthma.
I
Intervention
Correction of serum potassium concentration and insertion of an implantable cardioverter defibrillator (ICD).
O
Outcome
Recurrence of malignant ventricular arrhythmia and syncope.hard clinical

Hypokalemia that does not induce QT prolongation may contribute to the occurrence of ventricular tachycardia and fibrillation in patients with Brugada syndrome.

Abstract

A 60-year-old man with asymptomatic Brugada syndrome and neither a history of syncope nor family history of sudden death was admitted because of bronchial asthma. Serum potassium concentration was 3.8 mmol/L on admission, and decreased to 3.1 mmol/L on the 6th day, probably as a side effect of steroid therapy. The patient was found unconscious on the 7th day, and his serum potassium concentration was 3.4 mmol/L immediately after the episode. On the 8th day, the patient was again found unconscious, and polymorphic ventricular tachycardia and fibrillation (VT/VF) was documented on electrocardiographic (ECG) monitoring. The coved type of ST-segment elevation in leads V(1-3) was observed on the ECG after spontaneous recovery of sinus rhythm, and VT/VF associated with Brugada syndrome was diagnosed. The serum potassium concentration decreased to 2.9 mmol/L immediately after the episode, but QT prolongation was not observed during the clinical course. After the correcting the serum potassium concentration, there was no further recurrence of the malignant ventricular arrhythmia and syncope. An implantable cardioverter defibrillator was inserted to prevent sudden death. Hypokalemia that does not induce QT prolongation may contribute to the occurrence of VT/VF in Brugada syndrome.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Araki et al. (2002) studied this question.

synapsesocial.com/papers/6a90f2cb097347c7becae3ebhttps://doi.org/10.1253/circj.67.93
Ask AI
Helpful
Bookmark
Share
View Full Paper